Literature DB >> 21225296

Blood-CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery.

Hari S Sharma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21225296     DOI： 10.1007/s00702-010-0542-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


× No keyword cloud information.
  24 in total

Review 1.  Neurotrophic factors in combination: a possible new therapeutic strategy to influence pathophysiology of spinal cord injury and repair mechanisms.

Authors:  Hari Shanker Sharma
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 2.  Novel therapeutics for Alzheimer's disease: an update.

Authors:  David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Journal:  Curr Opin Drug Discov Devel       Date:  2010-03

Review 3.  Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later.

Authors:  Gregory F Oxenkrug
Journal:  Isr J Psychiatry Relat Sci       Date:  2010       Impact factor: 0.481

4.  Serotonin synthesis from tryptophan by hypothalamic cells in serum-free medium culture.

Authors:  D Becquet; A M Francois-Bellan; F Boudouresque; M Faudon; F Hery; V Guillaume; M Hery
Journal:  Brain Res Dev Brain Res       Date:  1990-06-01

5.  PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid.

Authors:  Lucia Bondioli; Luca Costantino; Antonio Ballestrazzi; Davide Lucchesi; Diana Boraschi; Federica Pellati; Stefania Benvenuti; Giovanni Tosi; Maria A Vandelli
Journal:  Biomaterials       Date:  2010-02-04       Impact factor: 12.479

Review 6.  Parkinson's disease: Exit toxins, enter genetics.

Authors:  Marie Westerlund; Barry Hoffer; Lars Olson
Journal:  Prog Neurobiol       Date:  2009-11-17       Impact factor: 11.685

7.  Nano-drug delivery and neuroprotection in spinal cord injury.

Authors:  Hari S Sharma; Syed Ali; Z Ryan Tian; Ranjana Patnaik; S Patnaik; Per Lek; Aruna Sharma; Torbjörn Lundstedt
Journal:  J Nanosci Nanotechnol       Date:  2009-08

Review 8.  New perspectives for the treatment options in spinal cord injury.

Authors:  Hari Shanker Sharma
Journal:  Expert Opin Pharmacother       Date:  2008-11       Impact factor: 3.889

9.  Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy.

Authors:  Hari S Sharma; Eugene A Kiyatkin
Journal:  J Chem Neuroanat       Date:  2008-08-19       Impact factor: 3.052

10.  GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.

Authors:  Yazhou Li; TracyAnn Perry; Mark S Kindy; Brandon K Harvey; David Tweedie; Harold W Holloway; Kathleen Powers; Hui Shen; Josephine M Egan; Kumar Sambamurti; Arnold Brossi; Debomoy K Lahiri; Mark P Mattson; Barry J Hoffer; Yun Wang; Nigel H Greig
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205
View more
  1 in total

1.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.